Professor Heisler investigates brain circuits regulating energy homeostasis in an effort to identify new targets amenable to obesity and type 2 diabetes medications. She received her PhD from Tufts University in 1997 and following held postdoctoral positions at the University of California, San Francisco and Beth Israel Deaconess Medical Center, Harvard Medical School. In 2001, Professor Heisler was promoted to Instructor and set up her laboratory at Harvard Medical School. She then relocated her group to the University of Cambridge, UK in 2004 where they worked until 2013. In 2013, the Heisler group moved to the Rowett Institute to take advantage of the Institute’s strengths in obesity research, ranging from molecules to man. Professor Heisler was the recipient of the 2018 Outstanding Scientific Achievement Award (OSAA) from the American Diabetes Association for her research identifying a new type of medication to improve type 2 diabetes. This prestigious award recognizes diabetes research that demonstrates particular independence of thought and originality.